Herein, we performed biostatistics analysis using public datasets available from TCGA and REMBRANDT databases and interestingly found that high PPARγ expression is significantly associated with poor prognosis of GBM patients regarding both disease-free and overall survival (Fig. 5a). The gene discussed is PPARG; the disease is glioblastoma.